Senyalització Oncogènica i del Desenvolupament
- Nombre de publicacions
- 127
Publicacions
-
Eritja N; Mirantes C; Llobet D; Yeramian A; Bergadà L; Dosil MA; Domingo M; Matias-Guiu X; Dolcet X
Long-Term Estradiot Exposure Is a Direct Mitogen for Insulin/EGF-Primed Endometriat Cells and Drives PTEN Loss-Induced Hyperplasic Growth
AMERICAN JOURNAL OF PATHOLOGY 183 277-287. .
-
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias
DISEASE MODELS & MECHANISMS 6 710-720. .
-
Maliszewska, Agnieszka; Leandro-Garcia, Luis J.; Castelblanco, Esmeralda; Macia, Anna; de Cubas, Aguirre; Gomez-Lopez, Gonzalo; Inglada-Perez, Lucia; Alvarez-Escola, Cristina; De la Vega, Leticia; Leton, Rocio; Gomez-Grana, Alvaro; Landa, Inigo; Cascon, Alberto; Rodriguez-Antona, Cristina; Borrego, Salud; Zane, Mariangela; Schiavi, Francesca; Merante-Boschin, Isabella; Pelizzo, Maria R.; Pisano, David G.; Opocher, Giuseppe; Matias-Guiu, Xavier; Encinas, Mario; Robledo, Mercedes
Differential Gene Expression of Medullary Thyroid Carcinoma Reveals Specific Markers Associated with Genetic Conditions
AMERICAN JOURNAL OF PATHOLOGY 182 350-362. .
-
Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X
Endometrial carcinoma: molecular alterations involved in tumor development and progression
ONCOGENE 32 403-413. .
-
Sorolla, Anabel; Yeramian, Andree; Valls, Joan; Dolcet, Xavier; Bergada, Laura; Llombart-Cussac, Antoni; Maria Marti, Rosa; Matias-Guiu, Xavier
Blockade of NF kappa B activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
MOLECULAR ONCOLOGY 6 530-541. .
-
Colas, Eva; Pedrola, Nuria; Devis, Laura; Ertekin, Tugce; Campoy, Irene; Martinez, Elena; Llaurado, Marta; Rigau, Marina; Olivan, Mireia; Garcia, Marta; Cabrera, Silvia; Gil-Moreno, Antonio; Xercavins, Jordi; Castellvi, Josep; Garcia, Angel; Ramon y Cajal, Santiago; Moreno-Bueno, Gema; Dolcet, Xavier; Alameda, Francesc; Palacios, Jose; Prat, Jaime; Doll, Andreas; Matias-Guiu, Xavier; Abal, Miguel; Reventos, Jaume
The EMT signaling pathways in endometrial carcinoma
CLINICAL & TRANSLATIONAL ONCOLOGY 14 715-720. .
-
Fico, Annalisa; De Chevigny, Antoine; Egea, Joaquim; Boesl, Michael R.; Cremer, Harold; Maina, Flavio; Dono, Rosanna
Modulating Glypican4 Suppresses Tumorigenicity of Embryonic Stem Cells While Preserving Self-Renewal and Pluripotency
Stem Cells 30 1863-1874. .
-
Macia, A.; Gallel, P.; Vaquero, M.; Gou-Fabregas, M.; Santacana, M.; Maliszewska, A.; Robledo, M.; Gardiner, J. R.; Basson, M. A.; Matias-Guiu, X.; Encinas, M.
Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma
ONCOGENE 31 3961-3972. .
-
Montserrat, Nuria; Mozos, Ana; Llobet, David; Dolcet, Xavier; Pons, Cristina; Garcia de Herreros, Antonio; Matias-Guiu, Xavier; Prat, Jaime
Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma
HUMAN PATHOLOGY 43 632-643. .
-
Eritja, Nuria; Mirantes, Cristina; Llobet, David; Masip, Gemma; Matias-Guiu, Xavier; Dolcet, Xavi
ER alpha-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNF alpha and IL1 alpha in lumen formation and maintenance
JOURNAL OF CELL SCIENCE 125 1929-1944. .
-
Llaurado, Marta; Abal, Miguel; Castellvi, Josep; Cabrera, Silvia; Gil-Moreno, Antonio; Perez-Benavente, Asumpcio; Colas, Eva; Doll, Andreas; Dolcet, Xavier; Matias-Guiu, Xavier; Vazquez-Levin, Monica; Reventos, Jaume; Ruiz, Anna
ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells
INTERNATIONAL JOURNAL OF CANCER 130 1532-1543. .
-
Yeramian, Andree; Sorolla, Anabel; Velasco, Ana; Santacana, Maria; Dolcet, Xavier; Valls, Joan; Abal, Leandre; Moreno, Sara; Egido, Ramon; Casanova, Josep M.; Puig, Susana; Vilella, Ramon; Llombart-Cussac, Antonio; Matias-Guiu, Xavier; Marti, Rosa M.
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
INTERNATIONAL JOURNAL OF CANCER 130 967-978. .